Follow-On Cancer Drugs Target Earlier Stages Than Initial Drugs: Implications Of The IRA Tomas J. Philipson, Qi Zhao, Deyu Zhang, Kira Fujibayashi, and Heather Johnson

https://www.healthaffairs.org/doi/full/10.1377/hlthaff.2025.00627?utm_medium=email&utm_source=linkedin+newsletter&utm_campaign=december+2025+issue&utm_content=ahead+of+print